 |
Oxandrolone |
|---|---|
| Trade Name | Oxandrin |
| Orphan Indication | Patients with Duchenne's muscular dystrophy and Becker's muscular dystrophy |
| USA Market Approval | USA |
| USA Designation Date | 1997-04-22 00:00:00 |
| Sponsor | Savient Pharmaceuticals, Inc.;One Tower Center Boulevard, 12th floor;East Brunswick, New Jersey, 08816 |
